Table 3:
Estimates of remaining years of life expectancy for females at exact age 40, stratified by HIV mode of acquisition, ART start year, and viral load (VL) suppression (<50 cells/ml), prior AIDS, and CD4 count (cells/μL) at follow-up start (2015 onwards).
| ART start: 1996–2014 | CD4 count: | 0–49 | 50–99 | 100–199 | 200–349 | 350–499 | ≥500 |
|---|---|---|---|---|---|---|---|
|
| |||||||
| Acquisition route: Injecting drug use (IDU) | VL suppressed, no prior AIDS | 16.2 (15.0, 17.4) | 18.0 (16.8, 19.2) | 21.7 (20.6, 22.9) | 26.7 (25.7, 27.7) | 31.1 (30.2, 32.0) | 34.1 (33.4, 34.9) |
| VL suppressed, prior AIDS | 11.6 (10.4, 12.8) | 13.1 (11.9, 14.3) | 16.4 (15.2, 17.6) | 21.0 (19.9, 22.2) | 25.6 (24.6, 26.6) | 29.0 (28.1, 29.9) | |
| VL unsuppressed, no prior AIDS | 13.0 (11.8, 14.2) | 14.6 (13.4, 15.8) | 18.0 (16.9, 19.2) | 22.8 (21.7, 24.0) | 27.4 (26.4, 28.4) | 30.7 (29.9, 31.6) | |
| VL unsuppressed, prior AIDS | 9.0 (7.9, 10.1) | 10.3 (9.1, 11.4) | 13.1 (11.9, 14.3) | 17.4 (16.2, 18.6) | 21.8 (20.6, 22.9) | 25.2 (24.1, 26.2) | |
|
| |||||||
| Acquisition route: Heterosexual sex | VL suppressed, no prior AIDS | 27.3 (26.3, 28.3) | 29.2 (28.3, 30.1) | 32.8 (32.1, 33.6) | 36.9 (36.3, 37.5) | 40.0 (39.5, 40.4) | 41.7 (41.4, 42.1) |
| VL suppressed, prior AIDS | 21.7 (20.5, 22.8) | 23.6 (22.5, 24.7) | 27.5 (26.5, 28.5) | 32.2 (31.4, 33.0) | 36.0 (35.4, 36.7) | 38.5 (38.0, 39.1) | |
| VL unsuppressed, no prior AIDS | 23.5 (22.4, 24.6) | 25.4 (24.4, 26.5) | 29.3 (28.4, 30.2) | 33.8 (33.0, 34.5) | 37.4 (36.9, 38.0) | 39.7 (39.3, 40.2) | |
| VL unsuppressed, prior AIDS | 18.0 (16.8, 19.1) | 19.8 (18.7, 21.0) | 23.7 (22.6, 24.8) | 28.6 (27.6, 29.5) | 32.8 (32.1, 33.6) | 35.7 (35.1, 36.4) | |
|
| |||||||
| Standardised | Overall: 35.8 (35.2, 36.4) | 19.4 (18.2, 20.5) | 23.2 (22.2, 24.3) | 27.8 (26.8, 28.7) | 33.6 (32.8, 34.3) | 37.6 (37.0, 38.1) | 40.2 (39.7, 40.6) |
|
| |||||||
| ART start: 2015–19 | CD4 count: | 0–49 | 50–99 | 100–199 | 200–349 | 350–499 | ≥500 |
|
| |||||||
| Acquisition route: Injecting drug use (IDU) | VL suppressed, no prior AIDS | 21.6 (20.5, 22.7) | 23.6 (22.5, 24.7) | 27.5 (26.5, 28.4) | 32.2 (31.3, 33.0) | 36.0 (35.4, 36.6) | 38.5 (38.0, 39.0) |
| VL suppressed, prior AIDS | 16.3 (15.1, 17.5) | 18.0 (16.9, 19.2) | 21.8 (20.7, 22.9) | 26.7 (25.7, 27.7) | 31.2 (30.3, 32.0) | 34.2 (33.5, 34.9) | |
| VL unsuppressed, no prior AIDS | 17.9 (16.7, 19.1) | 19.8 (18.6, 20.9) | 23.6 (22.5, 24.7) | 28.5 (27.6, 29.5) | 32.8 (32.0, 33.6) | 35.7 (35.0, 36.3) | |
| VL unsuppressed, prior AIDS | 13.0 (11.8, 14.2) | 14.6 (13.4, 15.8) | 18.1 (16.9, 19.3) | 22.9 (21.8, 24.0) | 27.5 (26.5, 28.5) | 30.3 (29.4, 31.2) | |
|
| |||||||
| Acquisition route: Heterosexual sex | VL suppressed, no prior AIDS | 32.7 (31.9, 33.5) | 34.4 (33.7, 35.1) | 37.5 (36.9, 38.0) | 40.7 (40.3, 41.1) | 42.1 (41.8, 42.4) | 42.7 (42.4, 43.0) |
| VL suppressed, prior AIDS | 27.4 (26.4, 28.4) | 29.3 (28.4, 30.2) | 32.9 (32.1, 33.6) | 36.9 (36.3, 37.5) | 40.0 (39.6, 40.4) | 41.8 (41.4, 42.1) | |
| VL unsuppressed, no prior AIDS | 29.2 (28.2, 30.1) | 31.0 (30.2, 31.9) | 34.4 (33.7, 35.1) | 38.2 (37.7, 38.8) | 40.9 (40.6, 41.3) | 42.0 (41.7, 42.3) | |
| VL unsuppressed, prior AIDS | 23.5 (22.4, 24.6) | 25.5 (24.5, 26.5) | 29.3 (28.4, 30.3) | 33.8 (33.1, 34.6) | 37.5 (36.9, 38.1) | 39.8 (39.3, 40.2) | |
|
| |||||||
| Standardised | Overall: 39.0 (38.5, 39.5) | 24.9 (23.9, 25.9) | 28.9 (27.9, 29.8) | 33.0 (32.2, 33.7) | 38.0 (37.4, 38.5) | 40.8 (40.4, 41.2) | 42.0 (41.7, 42.3) |